Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) drug delivery
platform DehydraTECH employs its patented technology to improve bio-absorption
and bioavailability of active ingredients while covering unpleasant tastes. A
recent article discussing the company’s technology reads, “Lexaria’s disruptive
DehydraTECH drug delivery platform is protected by a robust suite of patents
granted or pending worldwide. It has been proven effective in multiple
international studies in greatly assisting rapidity and quantity of absorption
of a range of lipophilic (i.e., fat-soluble), bioactive molecules – such as
those contained in cannabinoids (CBD), nicotine, non-steroidal
anti-inflammatory drugs (NSAIDs) and other molecules. DehydraTECH offers a
healthier, oral ingestion alternative to other delivery methods, such as
smoking, which has known negative consequences, to quickly and effectively
deliver the bioactive substances that cannabis and nicotine consumers are
seeking, as Lexaria points out in detail on its website.”
To view the full article, visit http://ibn.fm/aLYmB
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall dosing
and higher effectiveness of lipophilic active molecules. Lexaria has multiple
patents pending in over 40 countries around the world and has patents granted
in the USA and in Australia for utilization of its DehydraTECH™ delivery
technology. Lexaria’s technology provides increases in intestinal absorption
rates; more rapid delivery to the bloodstream; and important taste-masking
benefits, for orally administered bioactive molecules including cannabinoids,
vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other
molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment